Run time: 59m

  0      0

On-Demand eCasts

21EL-626 On-Demand eCast: Disaster Proofing Your Disaster Preparedness Plan

Expiration Date: Apr 20, 2024

Credits: None available.


Live Program Date: Wednesday, April 21, 2021
Program Number: 21EL-626

Educational Track: Quality Education
Topics: Accreditation, Cellular Therapy, Quality, Quality Systems, Standards
Intended Audience: Directors, Donor Recruitment Staff, Facilities that perform molecular testing, Hospital Blood Banks, Hospitals, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Physicians, Technologists, Transfusion Safety Officers
Teaching Level: Intermediate

(titles and affiliations at the time of the live program)

Director/Moderator: Ronit Slotky, PhD, MSc, Director, Cell Therapies Manufacturing Facility, Hackensack University Medical Center, Hackensack, NJ
Speakers: Ljiljana V. Vasovic, MD, Assistant Professor of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY; Ed Brindle, Quality Manager, Cellular Therapy & Transplantation, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences, Hamilton, Ontario, Canada

Program Description
With new infectious diseases, severe weather, civil unrests, material and supply shortages, cyber threats, we are frequently faced with new extreme scenarios to which we have to be prepared. The recent COVID-19 pandemic presented our global community with new challenges and forced us to be more resilient and creative than ever before. With cellular therapies becoming an increasingly integral part of the healthcare community providing a state-of-the-art lifesaving patient care has its unique challenges. These include safe transport of perishable products with demanding storage requirements, decreased revenues, shortage of unique materials, limited access to back-up facilities, product transportation, and complex communication and documentation requirements. All of which require strict adherence to regulatory and accreditation requirements. This program will review the current state of a global pandemic threat and describe the specific challenges faced by cell therapy collection and processing facilities and clinical transplant programs. We will discuss what changes are needed to current disaster plans including reassessment of our risk mitigation strategies. We also will review the need to improve organizational, national, and global coordination efforts and creation of support networks.

Learning Objectives
After participating in this educational activity, participants should be able to:

  • Discuss facilities experience during the COVID-19 pandemic emerging disaster, how they can disturb the daily workflow, and identify the specific challenges that cell therapy programs were faced with.
  • Describe how to apply the experiences learned to perform a risk assessment and make improvements to your current disaster plan.
  • List examples of changes to daily practices that can be used to absorb risk, insecurity, and instability in a volatile and ever-changing world.

How to Claim Continuing Education Credit

  • Single Viewers: if you registered as a single viewer, complete the evaluation found on the "CE Information" tab after watching the video. By submitting the evaluation, you are attesting to watching the presentation in its entirety.
  • Group Viewers: This is applicable for groups/facilities that purchased Group Viewing access for this program (registration will be verified prior to processing a group viewing attendance log). Group Viewing Coordinators should submit the attendance log to within 72 hours of the completion/viewing date. Once AABB receives an attendance log, each participant on the attendance log will be granted access as a single viewer to this program and will be required to complete the evaluation in order to claim continuing education credit. Each participant will be required to have an AABB account in order to access this program/platform. If a participant does not have an account, he/she can create one using the same email address provided on the attendance log.

Director & Moderator(s):


  • Dr. Ljiljana V. Vasovic, MD, New York-Presbyterian Hospital-Weill Cornell Medicine
  • Ed Brindle, Quality Manager, Cellular Therapy & Transplantation, Juravinski Hospital and Cancer Centre, Hamilton Health Sciences


  • 1.00 - General Continuing Education (GEN)
  • 1.00 - Florida Lab Personnel (FLP)
  • 1.00 - California Lab Personnel (CLP)

You must be logged in and own this session in order to post comments.